Characterization of Epstein-Barr virus Type I variants based on linked polymorphism among EBNA3A, -3B, and -3C genes (Q45420931)

14 December 2017

title

Characterization of Epstein-Barr virus Type I variants based on linked polymorphism among EBNA3A, -3B, and -3C genes (English)

1 reference

14 December 2017

0 references

1

1 reference

14 December 2017

2

1 reference

Elisabeth Puchhammer-Stöckl

14 December 2017

series ordinal

4

object named as

Elisabeth Puchhammer-Stöckl

1 reference

14 December 2017

Jan J Cornelissen

3

1 reference

14 December 2017

publication date

6 January 2006

1 reference

14 December 2017

1 reference

14 December 2017

volume

118

1 reference

14 December 2017

issue

1-2

1 reference

14 December 2017

page(s)

105-114

1 reference

Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

EBV persistence in memory B cells in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Cytotoxic T-lymphocyte responses to a polymorphic Epstein-Barr virus epitope identify healthy carriers with coresident viral strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

EBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Amino acids of Epstein-Barr virus nuclear antigen 3A essential for repression of Jkappa-mediated transcription and their evolutionary conservation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Two nonconsensus sites in the Epstein-Barr virus oncoprotein EBNA3A cooperate to bind the co-repressor carboxyl-terminal-binding protein (CtBP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Is EBV persistence in vivo a model for B cell homeostasis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Vaccine strategies against Epstein-Barr virus-associated diseases: lessons from studies on cytotoxic T-cell-mediated immune regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

The role of Epstein-Barr virus in neoplastic transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Epstein-Barr nuclear antigen-3 and -4 interact with RBP-2N, a major isoform of RBP-J kappa in B lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

B cells under influence: transformation of B cells by Epstein–Barr virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Epstein-Barr virus-recent advances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

EBV genes and B cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Epstein-Barr virus nuclear protein 3A domains essential for growth of lymphoblasts: transcriptional regulation through RBP-Jkappa/CBF1 is critical

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Novel intertypic recombinants of epstein-barr virus in the chinese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Latent gene sequencing reveals familial relationships among Chinese Epstein-Barr virus strains and evidence for positive selection of A11 epitope changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Sequence variation in the Epstein-Barr virus latent membrane protein 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

The immunology of Epstein-Barr virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Detection of a nuclear antigen 2 (EBNA2)-variant Epstein-Barr virus strain in two siblings with fatal lymphoproliferative disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Compartmentalization and transmission of multiple epstein-barr virus strains in asymptomatic carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Conservation of Epstein-Barr virus cytotoxic T-cell epitopes in posttransplant lymphomas: implications for immune therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Physical and functional interactions between the corepressor CtBP and the Epstein-Barr virus nuclear antigen EBNA3C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Coinfection with multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

The molecular epidemiology and evolution of Epstein-Barr virus: sequence variation and genetic recombination in the latent membrane protein-1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Multiple Epstein-Barr Virus Infections in Healthy Individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Biophysical and mutational analysis of the putative bZIP domain of Epstein-Barr virus EBNA 3C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Epstein-Barr virus and oncogenesis: from latent genes to tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Epstein-Barr virus: 40 years on

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic drift.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

7 January 2021

Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

7 January 2021

Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

7 January 2021

The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

7 January 2021

A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.11.020

7 January 2021

10.1016/J.VIRUSRES.2005.11.020

Identifiers

DOI

1 reference

14 December 2017

1 reference